Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
about
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmissionAn economic analysis of poliovirus risk management policy options for 2013-2052Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needsCharacterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern IsraelEstimation of polio infection prevalence from environmental surveillance data.Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.Prolonged excretion of type-2 poliovirus from a primary immune deficient patient during the transition to a type-2 poliovirus-free world, Israel, 2016.Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Poliovirus vaccination during the endgame: insights from integrated modeling.Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.Modelling Risk to US Military Populations from Stopping Blanket Mandatory Polio Vaccination.Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
P2860
Q33873406-411BA7EC-F230-4458-ACB8-2D20FE10722BQ35131980-D0ACFA6D-6101-460A-84E3-3CDFE1BCA3F3Q35662053-1544E5F7-7938-4DEB-96F1-EBDB5A4309B9Q35779660-747E1521-518E-4CC5-9BB4-AA637DDDA4ACQ35779733-CE178AAD-4CB7-4D1C-89E3-5D3B5653413CQ35779856-3CDC6BAE-F75B-4BDB-95B7-B9584B35F9C8Q35787304-02F64C9E-9A87-477A-887F-4B915736DB42Q35787331-FDA5756A-0C50-47E6-BC68-17CE9D58957AQ35968325-70C0758A-1720-4E19-A443-231C70E0E418Q36031421-55009D70-66A3-49E3-B103-9E62103D0BD4Q36035498-61A68471-90A0-4FE6-8872-274768682223Q36059286-5D89807F-A417-4589-9402-47C5C42CFE19Q36327491-02C3CF8B-7BB5-4C0B-82BB-4BCD5909E78EQ37542082-5ECDD727-5C42-4B8E-BB24-62009748EDCFQ37623610-8398F1AE-3460-4174-9D1A-88DDA3868F4CQ38661101-40DA6803-7F47-4E2E-A337-70EAA1DF1B4BQ38754363-225790C3-77E3-4B9F-A40D-CBB38FA0BAF4Q38796753-81FD868D-DCBE-42C6-A121-6640CF1485E5Q39258694-0863596E-B74E-45E0-B3DE-9190FEF1918AQ40071754-3CAC18ED-A659-4AC9-8421-AF5ED058EFD2Q43373067-E64D5348-BEBE-436E-9D96-8F92AB658463Q47556747-9FA983F4-59D6-48ED-97FD-89718EE0A622Q55114845-AA6CDB2D-165B-4B84-A2BA-4BEA7176C657Q58791913-4B41E919-C6C5-408F-8548-149B875A7649
P2860
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
@en
type
label
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
@en
prefLabel
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
@en
P2093
P2860
P50
P356
P1476
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
@en
P2093
Dominika A Kalkowska
Emilia Anis
Kimberly M Thompson
Steven G F Wassilak
P2860
P304
P356
10.1093/INFDIS/JIU674
P407
P577
2014-12-10T00:00:00Z